Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/2726
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baran, Yusuf | - |
dc.contributor.author | Öztekin, Coşkun | - |
dc.contributor.author | Başsoy, Esen Yonca | - |
dc.date.accessioned | 2017-01-05T12:36:30Z | - |
dc.date.available | 2017-01-05T12:36:30Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | Baran, Y., Öztekin, C., and Başsoy, E. Y. (2010). Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. Cancer Investigation, 28(6), 623-628. doi:10.3109/07357901003631056 | en_US |
dc.identifier.issn | 0735-7907 | - |
dc.identifier.uri | http://doi.org/10.3109/07357901003631056 | - |
dc.identifier.uri | http://hdl.handle.net/11147/2726 | - |
dc.description.abstract | In this study, we aimed to show the synergistic apoptotic effects of imatinib/fludarabine combination in human K562 chronic myleloid leukemia (CML) cells. There was a significant increase in cytotoxicity of combination of imatinib and fludarabine as compared to any agent alone. On the other hand, combination of both agents induced apoptosis significantly as confirmed by increases in caspase-3 enzyme activity and decreases in mitochondrial membrane potential. As a summary, the results of this study strongly suggest that combination of imatinib and fludarabine induced cell death synergistically comparing to only imatinib or fludarabine in human K562 CML cells. Copyright © 2010 Informa Healthcare USA, Inc. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Informa Healthcare | en_US |
dc.relation.ispartof | Cancer Investigation | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | BCR/ABL | en_US |
dc.subject | Chronic myeloid leukemia | en_US |
dc.subject | Fludarabine | en_US |
dc.subject | Imatinib | en_US |
dc.title | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | en_US |
dc.type | Article | en_US |
dc.authorid | TR119193 | en_US |
dc.institutionauthor | Baran, Yusuf | - |
dc.institutionauthor | Başsoy, Esen Yonca | - |
dc.department | İzmir Institute of Technology. Molecular Biology and Genetics | en_US |
dc.identifier.volume | 28 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 623 | en_US |
dc.identifier.endpage | 628 | en_US |
dc.identifier.wos | WOS:000278740000006 | en_US |
dc.identifier.scopus | 2-s2.0-77953182889 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.3109/07357901003631056 | - |
dc.identifier.pmid | 20307198 | en_US |
dc.relation.doi | 10.3109/07357901003631056 | en_US |
dc.coverage.doi | 10.3109/07357901003631056 | en_US |
dc.identifier.wosquality | Q4 | - |
dc.identifier.scopusquality | Q3 | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
crisitem.author.dept | 04.03. Department of Molecular Biology and Genetics | - |
Appears in Collections: | Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
6
checked on Nov 15, 2024
WEB OF SCIENCETM
Citations
6
checked on Oct 26, 2024
Page view(s)
264
checked on Nov 18, 2024
Download(s)
284
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.